# Acro Biomedical Co., Ltd. (ACBM)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ACBM/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -65.1K | $ -60.3K | $ 385.4K | $ -444.8K |
| 2025 | $ 0 | $ -103.6K | $ -201.0K | $ 325.5K | $ -387.0K |
| 2024 | $ -378.4K | $ -44.5K | $ -68.9K | $ 152.5K | $ -295.0K |
| 2023 | $ 0 | $ -7.80M | $ -17.2K | $ 141.0K | $ -257.0K |
| 2022 | $ 735.6K | $ -17.73M | $ -164.8K | $ 25.7K | $ 486.4K |
| 2021 | $ 1.42M | $ -9.15M | $ 355.8K | $ 50.4K | $ 643.7K |
| 2020 | $ 876.4K | $ -149.6K | $ -254.1K | $ 24.5K | $ 685.9K |
| 2019 | $ 2.00M | $ -479.6K | $ -77.1K | $ 46.3K | $ 798.2K |
| 2018 | $ 10.46M | $ 349.2K | $ 82.1K | $ 3.3K | $ 1.17M |
| 2017 | $ 2.63M | $ 115.0K | $ -662.1K | $ 41.4K | $ 591.6K |
| 2016 | $ 0 | $ -50.9K | $ -32.4K | $ 10.0K | $ -22.2K |
| 2015 | $ 0 | $ -22.8K | $ -37.6K | $ 0 | $ 14.8K |
| 2014 | $ 0 | $ -63.7K | $ -47.3K | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.87 |
| Liabilities / Eq | -1.01 |
| Current Ratio | 0.01 |

## Other views

- [Metrics](https://sponda.capital/en/ACBM.md)
- [Charts](https://sponda.capital/en/ACBM/charts.md)
- [Compare](https://sponda.capital/en/ACBM/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.